Skip to main content

Monica D’Arcy Receives New Investigator Award

Date July 12, 2022 Media Contact Nicole Swenarton | 732-284-6326 | ns1332@ifh.rutgers.edu Monica D’Arcy, PhD, MS, was named the recipient of the 2022 New Investigator Award from Rutgers Cancer Institute of New Jersey. Each year, Rutgers Cancer Institute selects new Members of its Cancer Center Support Grant (CCSG) Research Programs to receive New Investigator Awards to … Read More

Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic

Date July 2, 2022 Media Contact Nicole Swenarton | 732-284-6326 | ns1332@ifh.rutgers.edu   Members of racial and ethnic minority groups were less likely to obtain prescriptions to treat opioid addiction during the COVID-19 pandemic, according to a study by researchers at Rutgers and Indiana University. Writing in the medical journal JAMA Network Open, researchers said their findings give … Read More

Soko Setoguchi on Annals on Call Podcast

Date June 24, 2022 Media Contact Nicole Swenarton | 732-284-6326 | ns1332@ifh.rutgers.edu   PETS core faculty member, Dr. Soko Setoguchi, joined Dr. Robert Centor on the Annals on Call podcast from the Annals of Internal Medicine. She was interviewed with Dr. Jeffrey Carson, Provost, New Brunswick at Rutgers Biomedical and Health Sciences and Distinguished Professor of … Read More

Tobias Gerhard Elected New Member of American Epidemiological Society

Date June 14, 2022 Media Contact Nicole Swenarton | 732-284-6326 | ns1332@ifh.rutgers.edu   Tobias Gerhard, BSPharm, PhD, FISPE, Professor of Pharmacy and Epidemiology, Interim Director, Rutgers Institute for Health, Health Care Policy and Aging Research, and Founding Director of the Center for Pharmacoepidemiology and Treatment Science has been elected as a New Member of the American … Read More

Welcome Monica D’Arcy

Date May 26, 2022 Media Contact Nicole Swenarton | 732-284-6326 | ns1332@ifh.rutgers.edu The Rutgers Center for Pharmacoepidemiology and Treatment Science extends a warm welcome to Monica D’Arcy, MS, PhD, new Core Faculty at PETS and Rutgers Institute for Health, RBHS Instructor in Department of Medicine, Division of Medical Oncology, Section of Cancer Epidemiology and Health Outcomes … Read More

Therapy Can Support Medication Treatment for Opioid Use Disorder

By Michelle Edelstein Date: March 24, 2022 Media Contact Michelle Edelstein | 732-427-6232 | mse46@sph.rutgers.edu Counseling may help keep people in treatment, according to Rutgers study. Receiving psychosocial and behavioral therapy alongside medications for opioid use disorder leads to better treatment engagement and continuity, according to Rutgers researchers. To better understand the role of psychosocial and … Read More

Teens and Young Adults Overdosing on Drugs for Common Mental Health Issues

By Nicole Swenarton Date March 10, 2022 Media Contact Nicole Swenarton | 732-284-6326 | ns1332@ifh.rutgers.edu   A high number of teens and young adults with an overdose involving a benzodiazepine (BZD), like Xanax, or psychostimulant, like Adderall – medications commonly used to treat mental health issues like attention deficit hyperactivity disorder and anxiety disorders – have … Read More

Risk of Severe Allergic Reaction Higher with Two Intravenous Iron-Boosting Products

By Kitta MacPherson Date March 28, 2022 Media Contact Patti Verbanas | patti.verbanas@rutgers.edu Five products compared for safety in Rutgers analysis of Medicare database Two products commonly administered intravenously to replenish iron levels in the body have a much higher chance of provoking a severe allergic attack, according to Rutgers researchers who conducted a study analyzing … Read More

Only 1 in 4 People Needing Treatment Received Medication for Opioid Use Disorder in Past Year

By Patti Verbanas Date March 22, 2022 Media Contact Nicole Swenarton | 732-284-6326 | ns1332@ifh.rutgers.edu Medication for opioid use disorder was lowest among adolescents and adults ages 50 or older, Rutgers researcher finds Despite strong evidence that medication is the most effective treatment for opioid use disorder (OUD), adolescents and most adults who might benefit from … Read More